Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of S-amlodipine 2,5 mg and 5 mg in Hypertension Patients: Open-label, Local, Phase IV Study

NCT03038451 is registered in ClinicalTrials.gov with Neutec Ar-Ge San ve Tic A.Ş as lead sponsor.

NCT NCT03038451
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03038451 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of S-amlodipine 2,5 mg and 5 mg in Hypertension Patients: Open-label, Local, Phase IV Study
Lead sponsor
Neutec Ar-Ge San ve Tic A.Ş
Phase
Phase 4
Overall status
Completed
Start date
March 20, 2013
Completion date
February 14, 2017
Enrollment
43 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hypertension